Status: Completed (January 2021)
Enrollment start: May 2019
The CeliacShield Study™ is a clinical research study funded by the NIH (NCCIH) that assesses the ability of latiglutenase, an investigational drug, to protect the small intestine of celiac disease patients from damage caused by gluten exposure.